Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.

Kisler K, Nelson AR, Montagne A, Zlokovic BV.

Nat Rev Neurosci. 2017 Jul;18(7):419-434. doi: 10.1038/nrn.2017.48. Epub 2017 May 18. Review.

2.

Multiple Factors Involved in the Pathogenesis of White Matter Lesions.

Lin J, Wang D, Lan L, Fan Y.

Biomed Res Int. 2017;2017:9372050. doi: 10.1155/2017/9372050. Epub 2017 Feb 21. Review.

3.

Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: a case control study.

Tai SY, Chen CH, Chien CY, Yang YH.

BMC Neurol. 2017 Feb 23;17(1):40. doi: 10.1186/s12883-017-0800-y.

4.

Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain.

Kisler K, Nelson AR, Rege SV, Ramanathan A, Wang Y, Ahuja A, Lazic D, Tsai PS, Zhao Z, Zhou Y, Boas DA, Sakadžić S, Zlokovic BV.

Nat Neurosci. 2017 Mar;20(3):406-416. doi: 10.1038/nn.4489. Epub 2017 Jan 30.

5.

The blood-brain barrier in Alzheimer's disease.

Zenaro E, Piacentino G, Constantin G.

Neurobiol Dis. 2017 Nov;107:41-56. doi: 10.1016/j.nbd.2016.07.007. Epub 2016 Jul 15. Review.

6.

Hypertension and Dementia: Epidemiological and Experimental Evidence Revealing a Detrimental Relationship.

Perrotta M, Lembo G, Carnevale D.

Int J Mol Sci. 2016 Mar 8;17(3):347. doi: 10.3390/ijms17030347. Review.

7.

Association Between Glaucoma and the Risk of Dementia.

Su CW, Lin CC, Kao CH, Chen HY.

Medicine (Baltimore). 2016 Feb;95(7):e2833. doi: 10.1097/MD.0000000000002833.

8.

Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.

Nelson AR, Sweeney MD, Sagare AP, Zlokovic BV.

Biochim Biophys Acta. 2016 May;1862(5):887-900. doi: 10.1016/j.bbadis.2015.12.016. Epub 2015 Dec 17.

9.

Neurovascular coupling in humans: Physiology, methodological advances and clinical implications.

Phillips AA, Chan FH, Zheng MM, Krassioukov AV, Ainslie PN.

J Cereb Blood Flow Metab. 2016 Apr;36(4):647-64. doi: 10.1177/0271678X15617954. Epub 2015 Nov 24. Review.

10.

Shedding of soluble platelet-derived growth factor receptor-β from human brain pericytes.

Sagare AP, Sweeney MD, Makshanoff J, Zlokovic BV.

Neurosci Lett. 2015 Oct 21;607:97-101. doi: 10.1016/j.neulet.2015.09.025. Epub 2015 Sep 25.

11.

Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations.

Koizumi K, Wang G, Park L.

Cell Mol Neurobiol. 2016 Mar;36(2):155-65. doi: 10.1007/s10571-015-0256-9. Epub 2015 Sep 2. Review.

12.

Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1.

Ramanathan A, Nelson AR, Sagare AP, Zlokovic BV.

Front Aging Neurosci. 2015 Jul 15;7:136. doi: 10.3389/fnagi.2015.00136. eCollection 2015. Review.

13.

Characterization of Aldh2 (-/-) mice as an age-related model of cognitive impairment and Alzheimer's disease.

D'Souza Y, Elharram A, Soon-Shiong R, Andrew RD, Bennett BM.

Mol Brain. 2015 Apr 25;8:27. doi: 10.1186/s13041-015-0117-y.

14.

Cerebral autoregulation, beta amyloid, and white matter hyperintensities are interrelated.

Brickman AM, Guzman VA, Gonzalez-Castellon M, Razlighi Q, Gu Y, Narkhede A, Janicki S, Ichise M, Stern Y, Manly JJ, Schupf N, Marshall RS.

Neurosci Lett. 2015 Apr 10;592:54-8. doi: 10.1016/j.neulet.2015.03.005. Epub 2015 Mar 4.

15.

Myocardin in biology and disease.

Miano JM.

J Biomed Res. 2015 Jan;29(1):3-19. doi: 10.7555/JBR.29.20140151. Epub 2014 Dec 25. Review.

16.

Phosphodiesterase III inhibitor promotes drainage of cerebrovascular β-amyloid.

Maki T, Okamoto Y, Carare RO, Hase Y, Hattori Y, Hawkes CA, Saito S, Yamamoto Y, Terasaki Y, Ishibashi-Ueda H, Taguchi A, Takahashi R, Miyakawa T, Kalaria RN, Lo EH, Arai K, Ihara M.

Ann Clin Transl Neurol. 2014 Aug;1(8):519-33. doi: 10.1002/acn3.79. Epub 2014 Jul 8.

17.

Ageing and microvasculature.

Scioli MG, Bielli A, Arcuri G, Ferlosio A, Orlandi A.

Vasc Cell. 2014 Sep 16;6:19. doi: 10.1186/2045-824X-6-19. eCollection 2014. Review.

18.

P2Y receptors in Alzheimer's disease.

Erb L, Cao C, Ajit D, Weisman GA.

Biol Cell. 2015 Jan;107(1):1-21. doi: 10.1111/boc.201400043. Epub 2014 Oct 13. Review.

19.

The pericyte: a forgotten cell type with important implications for Alzheimer's disease?

Winkler EA, Sagare AP, Zlokovic BV.

Brain Pathol. 2014 Jul;24(4):371-86. doi: 10.1111/bpa.12152. Review.

20.

Cilostazol add-on therapy in patients with mild dementia receiving donepezil: a retrospective study.

Ihara M, Nishino M, Taguchi A, Yamamoto Y, Hattori Y, Saito S, Takahashi Y, Tsuji M, Kasahara Y, Takata Y, Okada M.

PLoS One. 2014 Feb 26;9(2):e89516. doi: 10.1371/journal.pone.0089516. eCollection 2014.

Supplemental Content

Support Center